To determine if the GLS2 and GLS inverse expression pattern we observed in the cell lines is also evident in breast cancer patient samples, we compared GLS and GLS2 copy numbers in samples from 1075 patients using data from The Cancer Genome Atlas (TCGA). The gene discussed is GLS2; the disease is breast carcinoma.